Intermittent hemodiafiltration as a down-step transition therapy in patients with acute kidney injury admitted to intensive care unit who initially underwent continuous venovenous hemodiafiltration

Abstract

Background/Aims:

Continuous renal replacement therapies (CRRT) are initially employed in patients with acute kidney injury (AKI) in ICU setting. After the period of serious illness, hemodialysis is usually used as a mode of transition from CRRT. Intermittent hemodiafiltration (HDF) is not commonly applied in this scenario.

Objectives:

To evaluate the feasibility of using HDF as transition therapy after CVVHDF in critically patients with AKI.

Methods:

An observational and prospective pilot study was conducted in ICU patients with dialysis-requiring AKI. Patients were initially treated with CVVHDF and, after medical improvement, those who still needed renal replacement therapy were switched to HDF treatment.

Results:

Ten Patients underwent 53 HDF sessions (mean of 5.3 sessions/patient). The main cause of renal dysfunction was sepsis (N = 7; 70%). The APACHE II mean score was 27.6 ± 6.9. During HDF treatment, the urea reduction ratio was 64.5 ± 7.5%, for β-2 microglobulin serum levels the percentage of decrease was 42.0 ± 7.8%, and for Cystatin C was 36.2 ± 6.9%. Five episodes of arterial hypotension occurred (9.4% of sessions). There were 20 episodes of electrolytic disturbance (37.7% of sessions), mainly hypophosphatemia. No pyrogenic or suggestive episode of bacteremia was observed.

Conclusion:

Hemodiafiltration was safe and efficient to treat critically ill patients with acute kidney injury during the transition phase from continuous to intermittent dialysis modality. Special attention should be paid regarding the occurrence of electrolytic disturbance, mainly hypophosphatemia.

Keywords

Acute renal failure artificial kidney apheresis & detoxification techniques dialysis adequacy hemodiafiltration sepsis solute kinetics in dialysis

Get full access to this article

View all access options for this article.

References

Bellomo

Ronco

Mehta

, et al. Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference. Ann Intensive Care 2017; 7(1): 49.

Cheung

Rocco

Yan

, et al. Serum ß2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 2006; 17(2): 546–555.

Canaud

Bragg-Gresham

Marshall

, et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 2006; 69(11): 2087–2093.

Maduell

Moreso

Pons

, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 2013; 24(3): 487–497.

Mercadal

Franck

Metzger

, et al. Hemodiafiltration versus Hemodialysis and survival in patients with ESRD: The French Renal Epidemiology and Information Network (REIN) Registry. Am J Kidney Dis 2016; 68(2): 247–255.

Daugirdas

JT.

Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4(5): 1205–1213.

Pegues

Oettinger

Bland

, et al. A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin. J Am Soc Nephrol 1992; 3(4): 1002–1007.

American Public Health Association. Standard methods for examination of water and wastewater. 22nd ed. Washington, DC: American Public Health Association, 2012.

Canaud

Bosc

Leray

, et al. Microbiological purity of dialysate for on-line substitution fluid preparation. Nephrol Dial Transplant 2000;15(Suppl. 2): 21–30.

10.

Klouche

Amigues

Serveaux-Delous

, et al. Implementing on-line hemodiafiltration as a renal replacement therapy for ICU acute renal failure: a single-center report of feasibility, safety and hemodynamic tolerance over a seven-year period. Blood Purif 2012; 34(1): 10–17.

11.

Klouche

Amigues

Morena

, et al. On-line hemodiafiltration did not induce an overproduction of oxidative stress and inflammatory cytokines in intensive care unit-acute kidney injury. BMC Nephrol 2017; 18(1): 371.

12.

VA/NIH Acute Renal Failure Trial Network; Palevsky

Zhang

O’Connor

, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359(1): 7–20.

13.

Kron

Wenkel

, et al. Extended daily on-line high-volume haemodiafiltration in septic multiple organ failure: a well-tolerated and feasible procedure. Nephrol Dial Transplant 2012; 27(1): 146–152.

14.

RENAL Replacement Therapy Study Investigators; Bellomo

Cass

Cole

, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009; 361(17): 1627–1638.

15.

Canaud

Chanine

Renaud

, et al. Optimal therapeutic conditions for online hemodiafiltration. Contrib Nephrol 2011; 168: 28–38.

16.

Asci

Toz

, et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant 2013; 28(1): 192–202.

17.

Grooteman

MPC

van den Dorpel

Bots

, et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 2012; 23(6): 1087–1096.

18.

Tattersall

Ward

RA.

Online haemodiafiltration: definition, dose quantification and safety revisited. Nephrol Dial Transplant 2013; 22: 542–550.

19.

Maduell

Is there an ‘Optimal Dose’ of hemodiafiltration?

Blood Purif 2015; 40(Suppl. 1): 17–23.

20.

Vilar

Boltiador

Viljoen

, et al. Removal and rebound kinetics of cystatin C in high-flux hemodialysis and hemodiafiltration. Clin J Am Soc Nephrol 2014; 9(7): 1240–1247.

21.

Maheshwari

Santhi

Malar

RJ.

Cystatin C: an alternative dialysis adequacy marker in high flux hemodialysis. Indian J Nephrol 2015; 25(3): 143–145.

22.

Park

Kim

Kang

, et al. Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules. Korean J Intern Med 2010; 25(1): 77–81.